InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Kay Christina. Insider active across 1 company, notably Integrated Biopharma INC. Aggregated, 4 reports have been logged. Activity tracked since 30 May 2023. The latest transaction was disclosed on 21 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
KAY CHRISTINA is a declarant linked to Integrated Biopharma INC, where she is Co-Chief Executive Officer. She has 4 filings in total, and the recent sampled filings cover the period from 2023-06-01 to 2025-05-22, with the transaction nature shown as Attribution; the buy and sell amounts recorded in this sample are 0 and 0 EUR.